ConductScience.org, home

Library / Genes

MYH11: myosin heavy chain 11

1 protein, 66 patents, 0 drugs, 0 trials, 3,344 NIH grants and 5,014 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolMYH11HGNC
Namemyosin heavy chain 11HGNC
NCBI Gene ID4629NCBI Gene
HGNC IDHGNC:7569HGNC
EnsemblENSG00000133392NCBI Gene
AliasesAAT4, FAA4, SMHC, SMMHC, SMMS-1, VSCM2NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P35749Myosin-111,9721Ensembl, GeneID, HGNCUniProt

Patents 66

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1454698P35749Espacenet
EP 4650780 A22025-11-193976P35749Espacenet
EP 4641201 A22025-10-293556P35749Espacenet
JP 2025517969 A2025-06-123556P35749Espacenet
JP 2025517970 A2025-06-123976P35749Espacenet
JP 2025032204 A2025-03-1131942P35749Espacenet
JP 2025032204 A2025-03-1131946P35749Espacenet
EP 4461818 A22024-11-1331942P35749Espacenet
EP 4461818 A22024-11-1331946P35749Espacenet
US 11708610 B22023-07-25664P35749Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3344

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant522,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)242,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award222,025NIH's project files
P30CA008748Cancer Center Support Grant202,025NIH's project files
P30CA016058Cancer Center Support Grant192,025NIH's project files
ZIAHG000030Mechanistic and translational studies of CBF leukemia142,025NIH's project files
U10CA180886COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement132,025NIH's project files
U10CA180899Children's Oncology Group Statistics and Data Center112,025NIH's project files
T32HL007284Basic Cardiovascular Research Training Grant102,025NIH's project files
P30CA091842Cancer Center Support Grant92,025NIH's project files

Papers 5014

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42823170PubTator, text miningPubMed
42800172PubTator, text miningPubMed
42792907PubTator, text miningPubMed
42779869PubTator, text miningPubMed
42774489PubTator, text miningPubMed
42726671PubTator, text miningPubMed
42710154PubTator, text miningPubMed
42662145PubTator, text miningPubMed
42645202PubTator, text miningPubMed
42640698PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license